Category: Legislative

Group That Does Not Disclose Its Funding Releases White Paper Calling for 340B Reforms, Advocates Slam Report

October 24, 2024 Shannon Young, Associate Editor/Senior Writer Views

The Health Equity Collaborative called for 340B program overhauls in a new white paper.

An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

October 22, 2024 Shannon Young, Associate Editor/Senior Writer Views

More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.

The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Dark Money Poured Nearly $4M into Super PAC Opposing State 340B Contract Pharmacy Access Bills

October 18, 2024 William Newton, Associate Editor/Senior Writer Views

Stand for US PAC received $3.8 million in contributions over the last three months from a conservative dark money group.

A political action committee (PAC) that funded efforts opposing state 340B contract pharmacy access bills through misleading claims linking the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law

October 3, 2024 William Newton, Associate Editor/Senior Writer Views

The Arkansas Insurance Department held a preliminary hearing with attorneys for AstraZeneca on Oct. 1.

Arkansas officials initiated enforcement proceedings earlier this week against AstraZeneca for allegedly violating a state law that prohibits drugmaker 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Judge Upholds Louisiana’s 340B Contract Pharmacy Law in Another Major Blow to Drug Industry

September 30, 2024 William Newton, Associate Editor/Senior Writer Views

A federal court upheld Louisiana’s contact pharmacy law this week, drawing praise from provider groups and criticism from the drug industry in the latest of such challenges across the nation.

A federal judge moments ago dismissed three drug industry challenges to Louisiana’s 340B contract pharmacy access law in another major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

High-Ranking HRSA Official Talks Genesis Decision, Drugmaker Audits During Rare Unscripted Q&A at Industry Conference

September 26, 2024 William Newton, Associate Editor/Senior Writer Views

Lisa Scholz interviewed HRSA's OPA Director Chantelle Britton at the MDRP Summit in Chicago.

A high-ranking federal regulator addressed the 340B patient definition and manufacturer audits during an unscripted Q&A session after a speech [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lawmakers Hit Campaign Trail Without Unveiling Highly Anticipated SUSTAIN 340B Act

September 26, 2024 Shannon Young, Associate Editor/Senior Writer Views

The “Group of Six” is expected to announce this week that it plans to release the SUSTAIN Act by the end of the year.

Members of Congress are headed back to their districts this week to campaign ahead of the November elections without unveiling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sen. Cassidy’s Letters to Drug Manufacturers Welcomed by Drug Industry Trade Group, Draw Skepticism from 340B Provider Advocates

September 24, 2024 Bella Czajkowski and Shannon Young, National Correspondent Views

The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract pharmacy restrictions as part of an ongoing congressional probe of the drug pricing program.

The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Delaware Enacts 340B-PBM Payment Law Without Contract Pharmacy Provisions from Original Version

September 24, 2024 William Newton, Associate Editor/Senior Writer Views

Delaware enacted a law prohibiting PBMs from limiting payments to healthcare providers based on their 340B status.

Delaware Gov. John Carney (D) late last week signed into law a bill to prohibit “discrimination against 340B entities by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senator Cassidy Extends 340B Inquiry to Two Major Pharmaceutical Manufacturers

September 23, 2024 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy (R-La.) has extended an ongoing 340B probe to two major drug manufacturers.

An influential Republican senator this morning requested detailed information from Eli Lilly and Amgen on their 340B programs, including the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Legislative

Group That Does Not Disclose Its Funding Releases White Paper Calling for 340B Reforms, Advocates Slam Report

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Dark Money Poured Nearly $4M into Super PAC Opposing State 340B Contract Pharmacy Access Bills

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Federal Judge Upholds Louisiana’s 340B Contract Pharmacy Law in Another Major Blow to Drug Industry

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

High-Ranking HRSA Official Talks Genesis Decision, Drugmaker Audits During Rare Unscripted Q&A at Industry Conference

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Lawmakers Hit Campaign Trail Without Unveiling Highly Anticipated SUSTAIN 340B Act

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Sen. Cassidy’s Letters to Drug Manufacturers Welcomed by Drug Industry Trade Group, Draw Skepticism from 340B Provider Advocates

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Delaware Enacts 340B-PBM Payment Law Without Contract Pharmacy Provisions from Original Version

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Senator Cassidy Extends 340B Inquiry to Two Major Pharmaceutical Manufacturers

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live